Mitesco (MITI) CEO Brian Valania Receives Grants

What Happened
Brian Valania, CEO and director of Mitesco, received multiple board-approved awards (all coded "A" for grant/acquisition). The grants include common-stock awards and Series X preferred-share awards. Key items reported: 200,000 common shares at $0.25 ($50,000) on 2024-07-29; 221,078 common shares at $0.08 ($17,686) on 2026-07-21; 3,000,000 common shares at $0.04 ($105,000) on 2026-08-03; and two Series X preferred grants (derivative) of 2,400 shares at $400 each ($960,000) on 2026-05-01 and 4,800 shares at $400 each ($1,920,000) on 2026-07-10. These are awards/compensation (not open-market purchases or sales).

Key Details

• Transaction dates & prices:
  • 2024-07-29: 200,000 common @ $0.25 = $50,000
  • 2026-07-21: 221,078 common @ $0.08 = $17,686
  • 2026-08-03: 3,000,000 common @ $0.04 = $105,000
  • 2026-05-01: 2,400 Series X preferred @ $400 = $960,000 (derivative)
  • 2026-07-10: 4,800 Series X preferred @ $400 = $1,920,000 (derivative)
• Shares owned after grants (as reported):
  • Common: after 07/10/26 grant = 421,078 shares; after 08/03/26 grant = 3,421,078 shares
  • Series X preferred: after 07/10/26 grant = 7,200 preferred shares
• Footnote/convertibility: Footnote F1 states the Series X Preferred "has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it." The filing's remarks also note that conversion terms and any underlying common shares remain subject to counsel review — indicating some uncertainty about conversion mechanics.
• Filing timeliness: Form 4 filed 2026-08-24 while some transactions date back to 2024 and mid-2026; this appears late relative to the standard two-business-day Form 4 deadline.

Context
These entries are grants/awards (company compensation or board-approved grants), not open-market buys or sales; such awards are common for executive compensation and do not alone signal immediate buying/selling intent. The Series X entries are preferred-share (derivative) awards with a stated $400 value each; per the filing the preferred currently lacks conversion rights, so they may not translate into common shares unless or until conversion terms are clarified. The filing does not report any immediate sale of shares.